How Our In Vitro Immuno-Oncology Immune Cell Infiltration Assay Can Accelerate Drug Discovery
One of the key benefits of our in vitro Immuno-Oncology Immune Cell Infiltration assay is its ability to create [...]
Accelerating Drug Discovery with High-Content Screening using HUREL® Micro Livers
High-content screening (HCS) is a powerful tool that allows for the assessment of multiple endpoints simultaneously at a cellular [...]
Accelerating Drug Discovery with Advanced In Vitro Models
Advanced in vitro models, such as our liver fibrosis model, are known to provide a more efficient and cost-effective [...]
Maximizing Drug Efficacy with In Vitro Blood Brain Barrier Permeability Assessment
Drug efficacy can be measured through various assays, such as anti-proliferative effect, assessment of cell viability after treatment, and [...]
Accelerating Drug Discovery with In Vitro Antibody Pharmacokinetics Assay
Drug discovery and development is a complex process that involves identifying potential drug candidates, testing them in vitro and [...]
Maximizing the Potential of Liver Fibrosis Assay
Drug discovery is a complex and challenging process that requires a significant investment of time, resources, and expertise. One [...]
Unlocking New Possibilities in Drug Discovery with Highly-Multiplexed IHC
Immunohistochemistry (IHC) is a fundamental technique used to visualize specific cellular components within tissue samples. It plays a crucial [...]
Why 3D Cell Culture Matters
In recent years, there has been a growing interest in the use of 3D cell culture models for drug [...]
The Power of HUREL® Micro Livers in Predicting Drug Toxicity
Drug toxicity is a major concern in the pharmaceutical industry. It is essential to identify potential toxic effects of [...]
The Advantages of In Vitro Immuno-Oncology Models for Immunotherapy Development
Immunotherapy is a rapidly growing field in cancer treatment, with the aim of modulating tumor immunity to promote tumor-rejection. [...]